Related Experiment Video
Updated: Aug 12, 2026
08:01
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM
Dina H Kassem1, Mohamed M Kamal2
1Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Trends in Endocrinology and Metabolism: TEM
|February 10, 2020
Abstract:
Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.
